Research Center

본문 바로가기
CALL

Global company representing the world

We continue to develop medical devices and cosmeceutical products containing bioactive substances.

  • Advancement of hyaluronic acid cross-linking technology

    Traditional cross-linking method

    Extensive modification of HA

    • * Side effects due to high chemical crosslinking
      * Decreased duration due to short chain bonding

    CCT cross-linking method

    Minimal modification of HA to stabilize the natural network

    • * Minimize side effects due to minimal chemical crosslinking
      * Increase durability by maintaining the long chain of hyaluronic acid
    Stable & High elasticity despite low chemical deformation

    CCT cross-linking method

    • Biphasic filler – Elasticity and phase angle

    • Monophasic filler – Elasticity and total BDDE

    • Spherical filler – Long lasting hyaluronic acid filler

      The world’s first commercialized Beaded long lasting filler with more safety and volumizing

      Optimized design for human body injection

      Macrophage activity affects physical chemistry such as particle size and chemical structure

      Normal HA filler

      * Larger area

      * Irregular shape
      → more stimulation to macrophage → more cytokine eruption → more inflammation

      VS
      Beaded HA filler

      * Smaller area

      * Soft and regular shape

    • Thermal Sensitive Spherical filler – Thermal Sensitive Elasticity

      The world’s first commercialized temperature sensitivity Beaded long lasting filler

      while showing an appropriate elasticity value at room temperature, after injection of temperature sensitivity filler, gradually increase elasticity and duration

    Diversification of hyaluronic acid fillers

    • Hyaluronic acid filler

      - Applying a new cross-linking method

      - Implementing minimization of side effects

      - Minimizing HA and cross-linking agent

      - Volumizing effects on the face

    • Temperature-sensitive filler

      - Higher safety compared to the existing fillers

      - Confirming the safety through clinical tests

      - Entering new markets with products whose safety efficacy has been secured by clinical tests

    • Mezzo filler

      - Applying high-purity raw materials derived from natural ingredients

      - Confirming the safety through clinical tests

      - Facilitating the time for wound healing

      - Confirming collagen production

COMPANY NAME YU | CEO | TEL +82-55-312-8020

Head office (HP)506-103, 10, Namoe 2-gil, Jung-gu, Ulsan, Republic of Korea
1st point (Medical Device Factory & Lab) 403, 80-59, Golden root-ro, Juchon-myeon, Gimhae-si, Gyeongsangnam-do, Republic of Korea
2nd point (Cosmetic factory) 111, 88, Somang-gil, Juchon-myeon, Gimhae-si, Gyeongsangnam-do, Republic of Korea

Company Registration Number 509-87-01716
Copyright © 2021 YU CO.,LTD.. All Rights Reserved.